Center for Applied Proteomics and Molecular Medicine (CAPMM)

Mason honors its COVID-19 surveillance testing team for its efforts during the pandemic.

A collaboration between the Honey Bee Initiative and Mason's new Forensic Science Research and Training Laboratory could yield critical advances in forensic science.

Two research professors at George Mason University, in collaboration with global partners, have discovered the same protein biomarkers in the saliva of youth and collegiate athletes who have experienced concussive and sub-concussive impacts.

Ceres Nanosciences, a Northern Virginia bioscience company spun out of George Mason University that specializes in diagnostic products and workflows, has opened a 12,000-square-foot advanced particle manufacturing plant in Prince William County’s Innovation Park.

During the coronavirus pandemic, Mason doctoral student Marissa Howard was able to get back into the Center for Applied Proteomics and Molecular Medicine (CAPMM) lab, but now all the researchers are working on COVID-19-related research.

COVID-19 antibody research by Mason scientists shows a lot of promise

A urine-based Lyme disease test created by a team of George Mason University researchers could soon become available statewide after a recent clinical validation study confirmed that it meets sensitivity and absolute molecular specificity standards.